Skip to main content
. 2021 Mar 20;41(3):329–335. [Article in Chinese] doi: 10.12122/j.issn.1673-4254.2021.03.03

2.

2

LDB2是肺腺癌患者预后良好的标志物

LDB2 is a prognosis biomarker for LUAD patients. The outcome of LUAD patients according to LDB2 expression was estimated by online databank GEPIA (A) and Prognoscan (B); C: The 80 cases of LUAD tissues were divided into 2 groups according to LDB2 expression. Kaplan-merier analysis were performed to estimate the relationship between LDB2 expression and prognosis of LUAD patients.